Women Experiencing Partner Violence More Motivated to Receive PrEP
FDA Advised to Update Labels on GLP-1 Weight-Loss Drugs
Growing Awareness: Movember Ignites a Mustache Revolution for Men’s Health
Racial, Ethnic Disparities Persist in Mortality for Patients With Early-Onset CRC
Low RSV Vaccination Rates in Nursing Homes Highlight Urgent Need for Uptake
Real-World Results of Durvalumab/Tremelimumab in U-HCC Show Promise Despite Line of Therapy
Key COVID-19 Recommendations for 2024-2025 Respiratory Virus Season
Communication Can Boost Medication Persistence in PAH
Viltolarsen Slows DMD Progression in Small Study
Age-Related Disparities in Long-Term Outcomes for ER+, HER2– Breast Cancer
Edentulism May Heighten Sleep Apnea Risk
Novel Relapsed/Refractory CLL Therapies Have Similar Safety Profiles
Health Equity & Access Weekly Roundup: November 23, 2024
FDA Accepts Resubmitted NDA for Ataluren in Nonsense Duchenne Muscular Dystrophy
A Case for Iron Deficiency as a Marker of Inequality in Care Access and Treatment
In-Room Air Purifiers Could Impact RSV Incidence Among Older Adults
Addressing Patent Hurdles, Payer Barriers, and Interchangeability
Early Palliative Care Linked to Better End-of-Life Outcomes in Ovarian Cancer
AJMC® in the Press, November 22, 2024
5 Things You Should Know About Long COVID
COVID-19 Infection Raises Myasthenia Gravis Exacerbation Risk, Study Finds
Frameworks for Advancing Health Equity: Wellness Way
Questions Loom as HHS Appointment Approaches
FDA Approves Zanidatamab-hrii for HER2+ Biliary Tract Cancer
Elevating Value in Cancer Care With Innovations, Accessibility, Equity
Study Finds Obesity May Worsen Multiple Sclerosis: Genetic Analysis Points to Causal Link
Treating Double-Exposed Patients With CLL: A Continued Unmet Need
HPV Vaccination Cost-Effective at Preventing Cervical Cancer in Patients With HIV
Semaglutide Eligibility Expands to Over Half of US Adults
Polygenic Risk Scores Can Identify Patients Who Should Receive IOP-Lowering Treatment